Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
BEHAVIORAL

Med-eMonitor

Participants will use the Med-eMonitor™ device, which is an electronic device that holds up to one month's supply of up to five medications. It is capable of cueing the taking of medication, warning patients when they are taking the wrong medication or taking it at the wrong time, recording side effect complaints, and through modem hookup promptly alerting treatment staff of failures to take medication as prescribed.

BEHAVIORAL

PharmCAT

Pharm CAT is a psychosocial intervention using environmental supports such as signs, alarms, checklists, and special medication containers to cue and sequence adaptive behavior in the patient's home environment. This treatment specifically targets adherence to medication, medication education, and orientation for patients with schizophrenia. Participants will receive weekly home visits from a case manager.

BEHAVIORAL

Treatment as Usual

Participants receiving standard treatment will keep the Med-eMonitor™ device in their homes throughout the study but will not use its medication reminder function.

Trial Locations (1)

78207

The University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00406718 - Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia | Biotech Hunter | Biotech Hunter